In the ischemia group, the percentage of CD3+/IGF-1+ cells among IGF-1+ cells was 26.46 ± 8.91%, which was dramatically reduced by MSC infusion to 13.14 ± 4.38% (Figures 5(i)–5(l) and 5(o)). This evidence concerns the gene IGF1 and ischemia.